Hydrochloric Acid

Hydrochloric Acid

SCHEMBL3277064

CC(S)N(C)C.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1129844 0.95
SCHEMBL17655237 0.95
SCHEMBL8411587 0.91
Acetic Acid SCHEMBL4576748 0.75 FFAR3 (0.44)
SCHEMBL4581144 0.73 CA2 (0.33)
Thiourea SCHEMBL7521017 0.73 NOS3 (0.33)
SCHEMBL3029608 0.73
Hydrochloric Acid SCHEMBL15233791 0.70
Hydrochloric Acid SCHEMBL2251934 0.70
Hydrochloric Acid SCHEMBL28141330 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637422-B2 Ionizable cationic lipid for RNA delivery ARCTURUS THERAPEUTICS, INC. (US) 2026-05-26 US disclosed
EP-4527831-A2 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY Arcturus Therapeutics, Inc. (US) 2025-03-26 EP disclosed
EP-4310075-A2 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY Arcturus Therapeutics, Inc. (US) 2024-01-24 EP disclosed
EP-3558943-B1 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY ARCTURUS THERAPEUTICS INC (US) 2023-10-18 EP disclosed
CN-114917203-A Ionizable cationic lipids for RNA delivery 阿克丘勒斯治疗公司 2022-08-19 CN disclosed
CN-110325511-B Ionizable cationic lipids for RNA delivery 阿克丘勒斯治疗公司 2022-04-19 CN disclosed
US-20210323914-A1 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY ARCTURUS THERAPEUTICS, INC. 2021-10-21 US disclosed
US-10961188-B2 Ionizable cationic lipid for RNA delivery ARCTURUS THERAPEUTICS, INC. (US) 2021-03-30 US disclosed
WO-2020148912-A1 LIGHT EMITTING ELEMENT, ELECTROLUMINESCENT DEVICE, AND MANUFACTURING METHOD OF LIGHT EMITTING ELEMENT シャープ株式会社 2020-07-23 WO disclosed
US-20200109113-A1 IONIZABLE CATIONIC LIPID FOR RNA DELIVERY ARCTURUS THERAPEUTICS, INC. 2020-04-09 US disclosed
US-4314820-A FOR TEXTILES CIBA-GEIGY CORPORATION (US) 1982-02-09 US disclosed
US-4278674-A ANTIBACTERIAL ANTIBIOTICS SANDOZ LTD. (CH) 1981-07-14 US disclosed
US-4254142-A Dithiocarbanilic acids and use thereof as immunosuppressive agent THE UPJOHN COMPANY (US) 1981-03-03 US disclosed
EP-0019702-A2 Distyrylebiphenyles, process for their preparation and their use for the optical brightening of organic materials, as well as detergent compositions, textile treating compositions and products for the after-treatment of laundry containing them CIBA-GEIGY AG (CH) 1980-12-10 EP disclosed
EP-0019078-A2 Distyrylebenzenes,process for their preparation and their use for the optical brightening of organic materials,as well as detergent compositions, textile treating compositions and products for the after-treatment of laundry containing such distyrylbenzenes CIBA-GEIGY AG (CH) 1980-11-26 EP disclosed
US-4208326-A ANTIBIOTICS SANDOZ LTD. (CH) 1980-06-17 US disclosed
US-4150156-A ANTIBIOTICS MERCK & CO., INC. (US) 1979-04-17 US disclosed
US-4123528-A ANTIBIOTICS MERCK & CO., INC. (US) 1978-10-31 US disclosed
US-4107164-A ANTIBIOTICS, ANTIBACTERIAL SANDOZ LTD. (CH) 1978-08-15 US disclosed
US-4032530-A ANTIBIOTICS SANDOZ LTD. (CH) 1977-06-28 US disclosed